Kingsley Crane: Tom, so I appreciated your comments on the applicability of the generative AI product outside of the typical customer base. But we just think about the core customer base, what do you think the potential is for generative AI to drive new trials? Or is this primarily a product that would work best as sort of second, third or fourth product within the basin?
Tom Siebel: I tell you, go look at the demo. People get awfully excited about it. And I just came back from somewhere. I know where Barcelona, okay, I just got off a plane from Barcelona, it shows to a bunch of people, Ed and I. And it’s a pretty exciting product. It’s something brand new. And you got to just take a look at it. It’s hard to describe. And I think it will make our products more attractive. It will make it easier for people to use, easier to handle change management, which is everything in enterprise applications. And so — and it will, I think, substantially differentiate us in the market. Take a look at this user interface compared to what SAP, Oracle, Salesforce and everybody else has in the market, which is just kind of a cheap copy of the Cboe version of the 7 architecture that Ed and I embedded in 2002. And this is something very different, and the excitement appears to be palpable.
Kingsley Crane: We’ve seen the demo we’re definitely really impressed by it. And so one for Juho. Wherever growth ends up next year in fiscal ’24, just want to think a little bit more about the balance of existing customer expansion and then the net new customer deals, like how much of the ramp in trial conversions are we factoring into growth next year?
Juho Parkkinen: Okay. Great question. So, I would suggest that you take a look at the assumptions that we provided and you model out based on the actuals that we have provided. And that just kind of give you a good idea as to where we should be as it rebates to the consumption-based business and happy to chat with you if you have any additional questions on it.
Operator: Thank you and one moment for our next question. And our next question comes from the line of Pat Walravens with JMP Securities. Your line is open. Please go ahead.
Pat Walravens: Great. Tom, one for you first. Can you just sort of give us an overview of how the business with the DoD is going? And maybe as a touch point to that, in December 2021, you guys signed the $500 million production other transaction agreements. How much of that is the DoD actually taken down? How much of the $500 million do they spend?
Tom Siebel: A good question, Pat, and I don’t know the answer. We have two agreements like that. One is for $500 million is one for $100 million. And I’m not sure I can tell you that our business with the DoD is looking very promising. There’s — I think we had — we hosted — Ed and I hosted, I think, A very large number of CIOs from DoD like two weeks ago on Army, Navy, Air Force, Cyber Command, Spacecom, Marines, National Guard, they were all in our office. And there are lots of discussions going on about some very significant projects. And so DoD is looking very promising. But I don’t know the answer to how much of that deal we’ve taken out. And we have a proposal in front of one of the agencies that will consume a lot of it, and we’ll see what happens.
Pat Walravens: Hopefully, that gets done. All right. And then Juho, I just wanted to — it was a very simple math there. But if I look at your Slide 20 I mean if I take your average TCV and I multiply it by the number of deals that you have for each quarter on the chart, I get your total bookings, right?
Juho Parkkinen: Yes. I think Pat that sounds about the right math, yes.
